Study ID,Patient ID,Sample ID,Abiraterone (ABI) and Enzalutamide (ENZA) Exposure Status,Diagnosis Age,Cancer Type,Cancer Type Detailed,Center of sequencing,Fraction Genome Altered,Mutation Count,Oncotree Code,Prior Treatment,Number of Samples Per Patient,Sample Type,Sex,Site Sequenced,Somatic Status,tumor content,Tumor Site,Tumor Typeprad_su2c_2015,1115153,1115153,Yes,54,Prostate Adenocarcinoma,Prostate Adenocarcinoma,DFCI,0.1332,51,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,Broad,Matched,34,Bone,Prostate adenocarcinomaprad_su2c_2015,1115154,1115154,No,49,Prostate Adenocarcinoma,Prostate Adenocarcinoma,DFCI,0.5771,56,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,Broad,Matched,80,Lymph node,Prostate adenocarcinomaprad_su2c_2015,1115156,1115156,No,78,Prostate Adenocarcinoma,Prostate Adenocarcinoma,DFCI,0.4228,50,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,Broad,Matched,69,Lymph node,Prostate adenocarcinomaprad_su2c_2015,1115157,1115157,Yes,71,Prostate Adenocarcinoma,Prostate Adenocarcinoma,DFCI,0.3934,77,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,Broad,Matched,38,Lymph node,Prostate adenocarcinomaprad_su2c_2015,1115161,1115161,No,67,Prostate Adenocarcinoma,Prostate Adenocarcinoma,DFCI,0.3063,78,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,Broad,Matched,87,Lymph node,Prostate adenocarcinomaprad_su2c_2015,1115183,1115183,No,63,Prostate Adenocarcinoma,Prostate Adenocarcinoma,DFCI,0.3894,46,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,Broad,Matched,64,Bone,Prostate adenocarcinomaprad_su2c_2015,1115202,1115202,No,70,Prostate Adenocarcinoma,Prostate Adenocarcinoma,DFCI,0.5632,79,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,Broad,Matched,44,Soft Tissue,Prostate adenocarcinomaprad_su2c_2015,1115244,1115244,Yes,70,Prostate Adenocarcinoma,Prostate Adenocarcinoma,DFCI,0.2499,70,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,Broad,Matched,50,Bone,Prostate adenocarcinomaprad_su2c_2015,6115114,6115114,Yes,80,Prostate Adenocarcinoma,Prostate Adenocarcinoma,MSKCC,0.269,181,PRAD,Had prior Taxane treatment,1,Metastasis,Male,Broad,Matched,89,Soft Tissue,Prostate adenocarcinomaprad_su2c_2015,6115115,6115115,Yes,79,Prostate Adenocarcinoma,Prostate Adenocarcinoma,MSKCC,0.5579,112,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,Broad,Matched,40,Lymph node,Prostate adenocarcinomaprad_su2c_2015,6115117,6115117,Yes,67,Prostate Adenocarcinoma,Prostate Adenocarcinoma,MSKCC,0.1998,78,PRAD,Had prior Taxane treatment,1,Metastasis,Male,Broad,Matched,52,Psoas Mass,Prostate adenocarcinomaprad_su2c_2015,6115118,6115118,Yes,69,Prostate Adenocarcinoma,Prostate Adenocarcinoma,MSKCC,0.4231,69,PRAD,Had prior Taxane treatment,1,Metastasis,Male,Broad,Matched,54,Soft Tissue,Prostate adenocarcinomaprad_su2c_2015,6115121,6115121,Yes,55,Prostate Adenocarcinoma,Prostate Adenocarcinoma,MSKCC,0.6306,61,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,Broad,Matched,67,Retroperitonium,Prostate adenocarcinomaprad_su2c_2015,6115122,6115122,Yes,55,Prostate Adenocarcinoma,Prostate Adenocarcinoma,MSKCC,0.5575,70,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,Broad,Matched,56,Lymph node,Prostate adenocarcinomaprad_su2c_2015,6115123,6115123,Yes,62,Prostate Adenocarcinoma,Prostate Adenocarcinoma,MSKCC,0.305,58,PRAD,Had prior Taxane treatment,1,Metastasis,Male,Broad,Matched,67,Neck Mass,Prostate adenocarcinomaprad_su2c_2015,6115219,6115219,Yes,68,Prostate Adenocarcinoma,Prostate Adenocarcinoma,MSKCC,0.7354,81,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,Broad,Matched,74,Lymph node,Prostate adenocarcinomaprad_su2c_2015,6115224,6115224,Yes,79,Prostate Adenocarcinoma,Prostate Adenocarcinoma,MSKCC,0.2194,88,PRAD,Had prior Taxane treatment,1,Metastasis,Male,Broad,Matched,70,Soft Tissue,Prostate adenocarcinomaprad_su2c_2015,6115227,6115227,Yes,81,Prostate Adenocarcinoma,Prostate Adenocarcinoma,MSKCC,0.1559,66,PRAD,Had prior Taxane treatment,1,Metastasis,Male,Broad,Matched,87,Soft Tissue,Prostate adenocarcinomaprad_su2c_2015,6115233,6115233,Yes,84,Prostate Adenocarcinoma,Prostate Adenocarcinoma,MSKCC,0.4895,86,PRAD,Had prior Taxane treatment,1,Metastasis,Male,Broad,Matched,84,Lymph node,Prostate adenocarcinomaprad_su2c_2015,6115234,6115234,No,66,Prostate Adenocarcinoma,Prostate Adenocarcinoma,MSKCC,0.374,62,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,Broad,Matched,32,Lymph node,Prostate adenocarcinomaprad_su2c_2015,6115237,6115237,No,81,Prostate Adenocarcinoma,Prostate Adenocarcinoma,MSKCC,0.5791,95,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,Broad,Matched,77,Liver,Prostate adenocarcinomaprad_su2c_2015,6115242,6115242,Yes,65,Prostate Adenocarcinoma,Prostate Adenocarcinoma,MSKCC,0.485,54,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,Broad,Matched,49,Soft Tissue,Prostate adenocarcinomaprad_su2c_2015,6115247,6115247,No,61,Prostate Adenocarcinoma,Prostate Adenocarcinoma,MSKCC,0.161,37,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,Broad,Matched,80,Lymph node,Prostate adenocarcinomaprad_su2c_2015,6115250,6115250,No,70,Prostate Adenocarcinoma,Prostate Adenocarcinoma,MSKCC,0.2491,96,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,Broad,Matched,95,Lymph node,Prostate adenocarcinomaprad_su2c_2015,6115251,6115251,No,71,Prostate Adenocarcinoma,Prostate Adenocarcinoma,MSKCC,0.3543,54,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,Broad,Matched,73,Lymph node,Prostate adenocarcinomaprad_su2c_2015,MO_1008,MO_1008,Yes,47,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.4092,71,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,47,Dura,Prostate adenocarcinomaprad_su2c_2015,MO_1012,MO_1012,No,71,Prostate Adenocarcinoma,Prostate Adenocarcinoma,MSKCC,0.5727,1071,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,53,Abdominal wall mass,Prostate adenocarcinomaprad_su2c_2015,MO_1013,MO_1013,Yes,55,Prostate Adenocarcinoma,Prostate Adenocarcinoma,MSKCC,0.5075,239,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,42,Lymph node,Prostate adenocarcinomaprad_su2c_2015,MO_1014,MO_1014,Yes,65,Prostate Adenocarcinoma,Prostate Adenocarcinoma,MSKCC,0.5218,131,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,62,Lymph node,Prostate adenocarcinomaprad_su2c_2015,MO_1015,MO_1015,No,75,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.6921,64,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,66,Lymph node,Prostate adenocarcinomaprad_su2c_2015,MO_1020,MO_1020,No,63,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.329,56,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,36,Liver,Prostate adenocarcinomaprad_su2c_2015,MO_1040,MO_1040,No,68,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.119,54,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,70,Lymph node,Prostate adenocarcinomaprad_su2c_2015,MO_1054,MO_1054,No,56,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.1494,46,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,30,Prostate,Prostate adenocarcinomaprad_su2c_2015,MO_1071,MO_1071,No,54,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.1365,54,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,33,Prostate,Prostate adenocarcinomaprad_su2c_2015,MO_1074,MO_1074,Yes,69,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.2179,93,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,43,Bone,Prostate adenocarcinomaprad_su2c_2015,MO_1084,MO_1084,No,77,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.5419,58,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,81,Lymph node,Prostate adenocarcinomaprad_su2c_2015,MO_1094,MO_1094,No,67,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.2884,45,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,85,Bone,Prostate adenocarcinomaprad_su2c_2015,MO_1095,MO_1095,No,72,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.4305,55,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,40,Thoracic epidural,Prostate adenocarcinomaprad_su2c_2015,MO_1096,MO_1096,No,66,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.316,62,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,66,Bone,Prostate adenocarcinomaprad_su2c_2015,MO_1114,MO_1114,Yes,62,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.6862,66,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,88,Lymph node,Prostate adenocarcinomaprad_su2c_2015,MO_1118,MO_1118,No,73,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.2323,42,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,91,Liver,Prostate adenocarcinomaprad_su2c_2015,MO_1124,MO_1124,No,66,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.3974,79,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,95,Bladder,Prostate adenocarcinomaprad_su2c_2015,MO_1128,MO_1128,No,71,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.3222,64,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,73,Lymph node,Prostate adenocarcinomaprad_su2c_2015,MO_1130,MO_1130,No,56,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.1037,26,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,36,Bone,Prostate adenocarcinomaprad_su2c_2015,MO_1161,MO_1161,Yes,65,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.4819,51,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,82,Liver,Prostate adenocarcinomaprad_su2c_2015,MO_1162,MO_1162,Yes,50,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.3598,86,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,61,Peritoneal nodule,Prostate adenocarcinomaprad_su2c_2015,MO_1176,MO_1176,No,56,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.2419,90,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,86,Lymph node,Prostate adenocarcinomaprad_su2c_2015,MO_1179,MO_1179,No,75,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.1992,72,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,30,Bone,Prostate adenocarcinomaprad_su2c_2015,MO_1184,MO_1184,No,71,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.3161,120,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,56,Liver,Prostate adenocarcinomaprad_su2c_2015,MO_1192,MO_1192,No,62,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.3006,47,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,68,Lymph node,Prostate adenocarcinomaprad_su2c_2015,MO_1202,MO_1202,No,70,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.5737,57,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,47,Liver,Prostate adenocarcinomaprad_su2c_2015,MO_1215,MO_1215,Yes,65,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.6415,154,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,88,Perirectal,Prostate adenocarcinomaprad_su2c_2015,MO_1219,MO_1219,No,68,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.1393,39,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,30,Bone,Prostate adenocarcinomaprad_su2c_2015,MO_1221,MO_1221,Yes,59,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.5436,51,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,79,Bone,Prostate adenocarcinomaprad_su2c_2015,MO_1232,MO_1232,Yes,65,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.6084,216,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,58,Chest Wall,Prostate adenocarcinomaprad_su2c_2015,MO_1241,MO_1241,No,75,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.5625,53,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,82,Liver,Prostate adenocarcinomaprad_su2c_2015,MO_1244,MO_1244,Yes,58,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.4515,48,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,94,Liver,Prostate adenocarcinomaprad_su2c_2015,MO_1249,MO_1249,Yes,70,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.3574,103,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,48,Lymph node,Prostate adenocarcinomaprad_su2c_2015,MO_1262,MO_1262,No,53,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.0918,78,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,83,Lymph node,Prostate adenocarcinomaprad_su2c_2015,MO_1263,MO_1263,Yes,65,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.1628,75,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,30,Lymph node,Prostate adenocarcinomaprad_su2c_2015,MO_1277,MO_1277,Yes,54,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.3306,62,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,87,Bone,Prostate adenocarcinomaprad_su2c_2015,MO_1316,MO_1316,Yes,70,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.2546,68,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,85,Lymph node,Prostate adenocarcinomaprad_su2c_2015,MO_1336,MO_1336,No,75,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.5038,64,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,59,Bone,Prostate adenocarcinomaprad_su2c_2015,MO_1337,MO_1337,No,62,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.285,54,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,84,Liver,Prostate adenocarcinomaprad_su2c_2015,MO_1339,MO_1339,No,78,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.6828,65,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,79,Lymph node,Prostate adenocarcinomaprad_su2c_2015,MO_1410,MO_1410,No,66,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.4931,155,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,45,Liver,Prostate adenocarcinomaprad_su2c_2015,SC_9001,SC_9001,Yes,44,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.6805,47,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,70,Liver,Prostate adenocarcinomaprad_su2c_2015,SC_9003,SC_9003,Yes,64,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.3116,52,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,34,Bone,Prostate adenocarcinomaprad_su2c_2015,SC_9005,SC_9005,Yes,71,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.4164,48,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,35,Bone,Prostate adenocarcinomaprad_su2c_2015,SC_9007,SC_9007,Yes,65,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.0072,39,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,52,Lymph node,Prostate adenocarcinomaprad_su2c_2015,SC_9008,SC_9008,NA,NA,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.2086,1255,PRAD,UNo Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,92,Liver,Prostate adenocarcinomaprad_su2c_2015,SC_9009,SC_9009,NA,NA,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.4832,63,PRAD,UNo Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,86,Lymph node,Prostate adenocarcinomaprad_su2c_2015,SC_9010,SC_9010,NA,NA,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.6571,112,PRAD,UNo Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,61,Lymph node,Prostate adenocarcinomaprad_su2c_2015,SC_9011,SC_9011,No,71,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.1325,44,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,53,Lymph node,Prostate adenocarcinomaprad_su2c_2015,SC_9012,SC_9012,No,74,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.1663,61,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,32,Liver,Prostate adenocarcinomaprad_su2c_2015,SC_9016,SC_9016,Yes,69,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.3329,67,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,32,Lymph node,Prostate adenocarcinomaprad_su2c_2015,SC_9017,SC_9017,No,66,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.8466,31,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,74,Liver,Prostate adenocarcinomaprad_su2c_2015,SC_9018,SC_9018,Yes,73,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.0274,48,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,55,Bone,Prostate adenocarcinomaprad_su2c_2015,SC_9019,SC_9019,Yes,85,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.1345,62,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,42,Bone,Prostate adenocarcinomaprad_su2c_2015,SC_9020,SC_9020,No,74,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.3567,82,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,70,Lymph node,Prostate adenocarcinomaprad_su2c_2015,SC_9021,SC_9021,Yes,60,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.6215,149,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,82,Lymph node,Prostate adenocarcinomaprad_su2c_2015,SC_9022,SC_9022,Yes,66,Prostate Adenocarcinoma,Prostate Adenocarcinoma,RM-ICR,0.3545,134,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,55,Penile,Prostate adenocarcinomaprad_su2c_2015,SC_9023,SC_9023,No,78,Prostate Adenocarcinoma,Prostate Adenocarcinoma,RM-ICR,0.577,74,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,67,Bone,Prostate adenocarcinomaprad_su2c_2015,SC_9024,SC_9024,Yes,73,Prostate Adenocarcinoma,Prostate Adenocarcinoma,RM-ICR,0.1778,75,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,30,Lymph node,Prostate adenocarcinomaprad_su2c_2015,SC_9026,SC_9026,No,65,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.3812,58,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,39,Bone,Prostate adenocarcinomaprad_su2c_2015,SC_9027,SC_9027,No,69,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.4486,161,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,44,Bone,Prostate adenocarcinomaprad_su2c_2015,SC_9028,SC_9028,No,71,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.1932,120,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,30,ProstateTURP,Prostate adenocarcinomaprad_su2c_2015,SC_9029,SC_9029,No,75,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.2998,141,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,98,Muscle,Prostate adenocarcinomaprad_su2c_2015,SC_9030,SC_9030,Yes,66,Prostate Adenocarcinoma,Prostate Adenocarcinoma,RM-ICR,0.7753,85,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,91,Muscle,Prostate adenocarcinomaprad_su2c_2015,SC_9031,SC_9031,No,40,Prostate Adenocarcinoma,Prostate Adenocarcinoma,RM-ICR,0.3188,40,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,67,Liver,Prostate adenocarcinomaprad_su2c_2015,SC_9032,SC_9032,Yes,80,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.5682,164,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,87,Lymph node,Prostate adenocarcinomaprad_su2c_2015,SC_9034,SC_9034,No,65,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.0463,138,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,30,Bone,Prostate adenocarcinomaprad_su2c_2015,SC_9035,SC_9035,No,70,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.4852,66,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,63,Lymph node,Prostate adenocarcinomaprad_su2c_2015,SC_9036,SC_9036,No,72,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.3116,62,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,46,Lymph node,Prostate adenocarcinomaprad_su2c_2015,SC_9037,SC_9037,No,65,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.2075,61,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,30,Liver,Prostate adenocarcinomaprad_su2c_2015,SC_9038,SC_9038,Yes,70,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.3435,104,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,58,Lymph node,Prostate adenocarcinomaprad_su2c_2015,SC_9039,SC_9039,Yes,64,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.6205,38,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,83,Lymph node,Prostate adenocarcinomaprad_su2c_2015,SC_9043,SC_9043,No,68,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.2834,46,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,75,Bone,Prostate adenocarcinomaprad_su2c_2015,SC_9046,SC_9046,Yes,72,Prostate Adenocarcinoma,Prostate Adenocarcinoma,RM-ICR,0.1754,86,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,30,Liver,Prostate adenocarcinomaprad_su2c_2015,SC_9047,SC_9047,Yes,73,Prostate Adenocarcinoma,Prostate Adenocarcinoma,RM-ICR,0.0653,1008,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,65,Bone,Prostate adenocarcinomaprad_su2c_2015,SC_9048,SC_9048,Yes,73,Prostate Adenocarcinoma,Prostate Adenocarcinoma,RM-ICR,0.1959,56,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,33,Bone,Prostate adenocarcinomaprad_su2c_2015,SC_9049,SC_9049,Yes,70,Prostate Adenocarcinoma,Prostate Adenocarcinoma,RM-ICR,0.1899,62,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,30,Bone,Prostate adenocarcinomaprad_su2c_2015,SC_9050,SC_9050,No,78,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.4262,80,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,75,Lymph node,Prostate adenocarcinomaprad_su2c_2015,SC_9054,SC_9054,No,72,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.6373,154,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,66,Lymph node,Prostate adenocarcinomaprad_su2c_2015,SC_9055,SC_9055,No,59,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.3967,79,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,33,Lymph node,Prostate adenocarcinomaprad_su2c_2015,SC_9056,SC_9056,No,60,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.1164,41,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,45,Bone,Prostate adenocarcinomaprad_su2c_2015,SC_9057,SC_9057,No,59,Prostate Adenocarcinoma,Prostate Adenocarcinoma,RM-ICR,0.2524,100,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,72,glans penis,Prostate adenocarcinomaprad_su2c_2015,SC_9058,SC_9058,Yes,70,Prostate Adenocarcinoma,Prostate Adenocarcinoma,RM-ICR,0.6404,216,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,73,Lymph node,Prostate adenocarcinomaprad_su2c_2015,SC_9059,SC_9059,Yes,61,Prostate Adenocarcinoma,Prostate Adenocarcinoma,RM-ICR,0.6317,59,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,82,Lymph node,Prostate adenocarcinomaprad_su2c_2015,SC_9060,SC_9060,Yes,65,Prostate Adenocarcinoma,Prostate Adenocarcinoma,RM-ICR,0.3347,138,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,41,Liver,Prostate adenocarcinomaprad_su2c_2015,SC_9061,SC_9061,Yes,71,Prostate Adenocarcinoma,Prostate Adenocarcinoma,RM-ICR,0.5626,204,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,65,Bone,Prostate adenocarcinomaprad_su2c_2015,SC_9062,SC_9062,Yes,54,Prostate Adenocarcinoma,Prostate Adenocarcinoma,RM-ICR,0.6104,70,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,74,Lymph node,Prostate adenocarcinomaprad_su2c_2015,SC_9063,SC_9063,Yes,66,Prostate Adenocarcinoma,Prostate Adenocarcinoma,RM-ICR,0.2272,58,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,60,Lymph node,Prostate adenocarcinomaprad_su2c_2015,SC_9065,SC_9065,No,78,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.1103,54,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,63,Bone,Prostate adenocarcinomaprad_su2c_2015,SC_9066,SC_9066,No,43,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.3483,31,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,57,Bone,Prostate adenocarcinomaprad_su2c_2015,SC_9068,SC_9068,No,74,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.5247,158,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,58,Lymph node,Prostate adenocarcinomaprad_su2c_2015,SC_9071,SC_9071,Yes,67,Prostate Adenocarcinoma,Prostate Adenocarcinoma,RM-ICR,0.35,88,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,30,Bone,Prostate adenocarcinomaprad_su2c_2015,SC_9072,SC_9072,Yes,74,Prostate Adenocarcinoma,Prostate Adenocarcinoma,RM-ICR,0.5313,169,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,45,Bone,Prostate adenocarcinomaprad_su2c_2015,SC_9073,SC_9073,Yes,65,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.3861,34,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,38,Lymph node,Prostate adenocarcinomaprad_su2c_2015,SC_9076,SC_9076,Yes,71,Prostate Adenocarcinoma,Prostate Adenocarcinoma,RM-ICR,0.4292,236,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,38,Lymph node,Prostate adenocarcinomaprad_su2c_2015,SC_9080,SC_9080,No,76,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.3694,75,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,77,Lymph node,Prostate adenocarcinomaprad_su2c_2015,SC_9081,SC_9081,No,69,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.0492,741,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,86,Lymph node,Prostate adenocarcinomaprad_su2c_2015,SC_9082,SC_9082,No,67,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.174,86,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,37,Bone,Prostate adenocarcinomaprad_su2c_2015,SC_9083,SC_9083,No,62,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.6176,237,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,62,Bone,Prostate adenocarcinomaprad_su2c_2015,SC_9084,SC_9084,Yes,62,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.5934,55,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,75,Lymph node,Prostate adenocarcinomaprad_su2c_2015,SC_9086,SC_9086,No,72,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.378,59,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,42,Bone,Prostate adenocarcinomaprad_su2c_2015,SC_9089,SC_9089,Yes,51,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.2264,44,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,85,Lymph node,Prostate adenocarcinomaprad_su2c_2015,SC_9090,SC_9090,No,73,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.2613,121,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,75,Bone,Prostate adenocarcinomaprad_su2c_2015,SC_9091,SC_9091,No,60,Prostate Adenocarcinoma,Prostate Adenocarcinoma,Karmanos Cancer Institute,0.0808,55,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,63,Bone,Prostate adenocarcinomaprad_su2c_2015,SC_9092,SC_9092,No,76,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Washington,0.311,163,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,75,Bone,Prostate adenocarcinomaprad_su2c_2015,SC_9093,SC_9093,No,56,Prostate Adenocarcinoma,Prostate Adenocarcinoma,Karmanos Cancer Institute,0.6933,172,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,72,Soft Tissue,Prostate adenocarcinomaprad_su2c_2015,SC_9094,SC_9094,Yes,61,Prostate Adenocarcinoma,Prostate Adenocarcinoma,RM-ICR,0.4908,177,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,55,Bone,Prostate adenocarcinomaprad_su2c_2015,SC_9096,SC_9096,Yes,82,Prostate Adenocarcinoma,Prostate Adenocarcinoma,RM-ICR,0.5688,194,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,63,Bone,Prostate adenocarcinomaprad_su2c_2015,SC_9097,SC_9097,Yes,70,Prostate Adenocarcinoma,Prostate Adenocarcinoma,RM-ICR,0.6447,179,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,82,Lymph node,Prostate adenocarcinomaprad_su2c_2015,SC_9099,SC_9099,Yes,79,Prostate Adenocarcinoma,Prostate Adenocarcinoma,RM-ICR,0.5914,188,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,86,Lymph node,Prostate adenocarcinomaprad_su2c_2015,SC_9100,SC_9100,Yes,74,Prostate Adenocarcinoma,Prostate Adenocarcinoma,RM-ICR,0.0433,208,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,20,Bone,Prostate adenocarcinomaprad_su2c_2015,SC_9103,SC_9103,Yes,68,Prostate Adenocarcinoma,Prostate Adenocarcinoma,RM-ICR,0.4381,158,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,74,Bone,Prostate adenocarcinomaprad_su2c_2015,SC_9104,SC_9104,Yes,70,Prostate Adenocarcinoma,Prostate Adenocarcinoma,RM-ICR,0.2577,127,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,65,Lymph node,Prostate adenocarcinomaprad_su2c_2015,SC_9107,SC_9107,Yes,65,Prostate Adenocarcinoma,Prostate Adenocarcinoma,RM-ICR,0.685,158,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,60,Liver,Prostate adenocarcinomaprad_su2c_2015,SC_9109,SC_9109,Yes,55,Prostate Adenocarcinoma,Prostate Adenocarcinoma,RM-ICR,0.3786,149,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,51,Lymph node,Prostate adenocarcinomaprad_su2c_2015,TP_2001,TP_2001,No,70,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.4726,40,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,50,Lymph node,Prostate adenocarcinomaprad_su2c_2015,TP_2009,TP_2009,No,58,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.2975,100,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,45,Bone,Prostate adenocarcinomaprad_su2c_2015,TP_2010,TP_2010,No,64,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.2916,67,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,73,Lymph node,Prostate adenocarcinomaprad_su2c_2015,TP_2020,TP_2020,Yes,55,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.2054,132,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,42,Bone,Prostate adenocarcinomaprad_su2c_2015,TP_2032,TP_2032,Yes,74,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.2376,64,PRAD,Had prior Taxane treatment,1,Metastasis,Male,U Michigan,Matched,57,Lymph node,Prostate adenocarcinomaprad_su2c_2015,TP_2034,TP_2034,No,51,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.2391,59,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,51,Bone,Prostate adenocarcinomaprad_su2c_2015,TP_2054,TP_2054,Yes,70,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.3629,155,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,45,Lymph node,Prostate adenocarcinomaprad_su2c_2015,TP_2060,TP_2060,No,72,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.0869,110,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,30,Lymph node,Prostate adenocarcinomaprad_su2c_2015,TP_2061,TP_2061,No,65,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.5905,82,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,67,Pelvic mass,Prostate adenocarcinomaprad_su2c_2015,TP_2064,TP_2064,No,71,Prostate Adenocarcinoma,Prostate Adenocarcinoma,U Michigan,0.6095,120,PRAD,No Prior Taxane Treatment,1,Metastasis,Male,U Michigan,Matched,68,Lymph node,Prostate adenocarcinoma